Longitudinal national surveys reflect steady challenges for AIDS drug assistance programs, 2017–2024
Frontiers in Public Health · 2026
DOI: 10.3389/fpubh.2026.1913359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2026. Verfasst von Erin Q Rogers und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, VA, United States. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, Anti-HIV Agents, Medical Assistance, HIV Infections. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
As part of the Ryan White HIV/AIDS Program, AIDS Drug Assistance Programs (ADAPs) provide HIV medications and insurance assistance to low-income people with HIV across all U. S. states, the District of Columbia, and territories. The share of clients receiving insurance assistance through ADAPs has grown considerably, particularly following the Affordable Care Act (ACA), requiring ADAPs to coordinate with an increasingly complex array of public and private payers. This is the first study to examine longitudinal trends in the challenges ADAPs report. We conducted a descriptive analysis of the challenges reported by ADAPs between 2017 and 2024 in the NASTAD National ADAP Monitoring Project Annual Reports. ADAP leaders rated seven insurance-related domains (2017–2024) and 10 general program domains (2021–2024) as Not, Somewhat, and Very Challenging. We categorized responses as “Not Challenging” or “Challenging” (Somewhat/Very). Between 46 and 51 ADAPs responded annually. Although the overall number of domains rated as challenging decreased over time, six were rated as challenging by >50% of ADAPs in every year assessed: mail order pharmacy limitations, client churn, high copay/coinsurance, maintenance of eligibility, IT and data-sharing issues, and staff turnover. Some challenges increased, including pharmacy network issues (15 to 27%; +12 percentage points, +78% relative), while others declined, including remote work (37 to 10%; −27 percentage points, −72% relative). Despite a modest overall decrease in reported challenges, insurance coordination and core-operational challenges persisted across the years assessed. Continued monitoring may be particularly important as anticipated Medicaid and Marketplace changes take effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, VA, United States.
- McCourt School of Public Policy, Georgetown University, Washington, DC, United States.
- NASTAD, Washington, DC, United States.
- University of Virginia School of Nursing, Charlottesville, VA, United States.
Förderung
- NIAID NIH HHS
Zitieren
APA
Rogers, E. Q., Killelea, A., Horn, T., Panagides, R., Keim-Malpass, J., Liu, F., Steen, A., & McManus, K. A. (2026). Longitudinal national surveys reflect steady challenges for AIDS drug assistance programs, 2017–2024. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2026.1913359
Vancouver
Rogers EQ, Killelea A, Horn T, Panagides R, Keim-Malpass J, Liu F, et al. Longitudinal national surveys reflect steady challenges for AIDS drug assistance programs, 2017–2024. Frontiers in Public Health. 2026. doi:10.3389/fpubh.2026.1913359
BibTeX
@article{Rogers2026,
author = {Rogers, Erin Q and Killelea, Amy and Horn, Tim and Panagides, Reanna and Keim-Malpass, Jessica and Liu, Feng and Steen, Amber and McManus, Kathleen A},
title = {Longitudinal national surveys reflect steady challenges for AIDS drug assistance programs, 2017–2024},
journal = {Frontiers in Public Health},
year = {2026},
doi = {10.3389/fpubh.2026.1913359}
}
EUVIMED